Additional information
| Active substance | Rivaroxaban |
|---|---|
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Anti-factor Xa activity can indirectly measure its effect but is not routinely monitored |
| Also known as | BAY 59-7939 |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | No significant effect on blood pressure |
| Trade name | Xarelto |
| Storage conditions | Store at 15В°C to 30В°C (59В°F to 86В°F) in a dry place |
| Chemical name | Rivaroxaban |
| Formula | C19H18ClN3O5S |
| Substance class | Anticoagulant |
| Main action | Inhibits thrombin formation by directly targeting Factor Xa |
| Half-life | 5 to 9 hours in healthy individuals, up to 11 to 13 hours in the elderly |
| Dosage (medical) | 10 mg, 15 mg, or 20 mg tablets once daily, depending on the condition being treated |
| Dosage (sports) | N/A |
| Effects | Reduces the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, treats deep vein thrombosis and pulmonary embolism, prevents blood clots in certain patients |
| Side effects | Bleeding, anemia, liver enzyme changes, dizziness, headache, rash |
| Use in sports | Not typically used in sports |
| Manufacturer | Bayer |
FACTIVE 320 mg Abdi Ibragim
Januvia 100mg Merckgroup
Norvacs 10 mg Pfizer
Seretide Disckus (Advair) 250 mcg Glaxosmithkline
Seretide Disckus (Advair) 500 mcg Glaxosmithkline
Pregnyl 5000 IE 1 Ampulle
Spiriva HandiHaler 18mg Boehringer Ingelheim
Champix Starter Pack Pfizer
Norvacs 5 mg Pfizer
Rovamycine 3.000.000 iu Eczacibasi
Primobol (Methenolon) 50 mg Balkan Pharmaceuticals
BIOSYNERGY RECOVERY3 PEPTIDE BLEND LIFETECH LABS
Champix 56 tabs Pfizer
Fostimon (Merional) 75 (HMG) IBSA
Rapid Combo Nouveaux Ltd
Clomiphencitrat Nouveaux Ltd
FUCIDIN 500 mg Abdi Ibragim 

Reviews
There are no reviews yet.